(VIMAB) VIMAB - Performance -19.1% in 12m
VIMAB performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-38.91%
#42 in Peer-Group
Rel. Strength
22.02%
#5985 in Stock-Universe
Total Return 12m
-19.06%
#35 in Peer-Group
Total Return 5y
-41.12%
#43 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 25.7 |
| High / Low | SEK |
|---|---|
| 52 Week High | 15.60 SEK |
| 52 Week Low | 6.88 SEK |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 40.77 |
| Buy/Sell Signal +-5 | 1.37 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: VIMAB (-19.1%) vs XLI (25.1%)
5y Drawdown (Underwater) Chart
Top Performer in Research & Consulting Services
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| HURN NASDAQ Huron Consulting |
-3.64% | 42.3% | 219% | 20.6 | 18.2 | 1.52 | 28.8% | 22.5% |
| STN NYSE Stantec |
4.62% | 31.1% | 270% | 44.2 | 27.7 | 1.63 | 62.7% | 11.5% |
| CRAI NASDAQ CRA International |
4.12% | 16.6% | 472% | 25.1 | 23.2 | 1.45 | 40.5% | 14.4% |
| CBZ NYSE CBIZ |
1.93% | -0.5% | 211% | 59 | 16.5 | 1.3 | 56.1% | 85.9% |
| RCMT NASDAQ RCM Technologies |
14.6% | 43.5% | 1514% | 14.9 | 12.8 | 1.36 | 57.0% | 56.5% |
| KBR NYSE KBR |
-8.14% | -24.6% | 127% | 16.1 | 12.6 | 0.58 | 36.0% | 29.5% |
| MG NYSE Mistras |
6.68% | 2.9% | 134% | 17 | 11.7 | 0.73 | -7.90% | -25.7% |
| EFX NYSE Equifax |
-1.94% | 8.77% | 58.2% | 53.3 | 34.8 | 1.35 | -43.0% | -11.7% |
Performance Comparison: VIMAB vs XLI vs S&P 500
XLI (Industrial Sector SPDR ETF) is the Sector Benchmark for VIMAB
| Total Return (including Dividends) | VIMAB | XLI | S&P 500 |
|---|---|---|---|
| 1 Month | -14.43% | 4.21% | 5.25% |
| 3 Months | -17.11% | 27.08% | 24.13% |
| 12 Months | -19.06% | 25.05% | 14.15% |
| 5 Years | -41.12% | 130.63% | 111.83% |
| Trend Score (consistency of price movement) | VIMAB | XLI | S&P 500 |
|---|---|---|---|
| 1 Month | -89.2% | 60.8% | 81% |
| 3 Months | -85.4% | 93.3% | 96.9% |
| 12 Months | -15% | 55.4% | 44.9% |
| 5 Years | -61.7% | 87.3% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XLI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th5.36 | -17.88% | -18.69% |
| 3 Month | %th5.36 | -34.77% | -33.22% |
| 12 Month | %th39.29 | -35.27% | -29.09% |
| 5 Years | %th21.43 | -74.47% | -72.21% |
FAQs
Does VIMAB (VIMAB) outperform the market?
No,
over the last 12 months VIMAB made -19.06%, while its related Sector, the Industrial Sector SPDR (XLI) made 25.05%.
Over the last 3 months VIMAB made -17.11%, while XLI made 27.08%.
Performance Comparison VIMAB vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
VIMAB vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -3.4% | -19.7% | -43.7% | -33% |
| US NASDAQ 100 | QQQ | -3.2% | -19.7% | -44.3% | -32% |
| German DAX 40 | DAX | -1.3% | -13% | -55.8% | -48% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -3.3% | -17.7% | -47.1% | -39% |
| Hongkong Hang Seng | HSI | -3% | -20.5% | -63.1% | -58% |
| India NIFTY 50 | INDA | -1.6% | -17.9% | -44% | -18% |
| Brasil Bovespa | EWZ | -5.9% | -23.2% | -68.7% | -29% |
VIMAB vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -2% | -20.3% | -47.8% | -44% |
| Consumer Discretionary | XLY | -2.9% | -17.6% | -36% | -37% |
| Consumer Staples | XLP | -3.7% | -15.1% | -45.3% | -28% |
| Energy | XLE | -3.7% | -21.5% | -39.6% | -19% |
| Financial | XLF | -4.1% | -19.5% | -48.6% | -49% |
| Health Care | XLV | -2.9% | -16.6% | -36.3% | -14% |
| Industrial | XLI | -3.5% | -18.6% | -51.5% | -44% |
| Materials | XLB | -5.7% | -18.7% | -48.2% | -25% |
| Real Estate | XLRE | -3.4% | -15.4% | -43.4% | -32% |
| Technology | XLK | -4.2% | -23.1% | -46% | -30% |
| Utilities | XLU | -2.3% | -16.2% | -46.9% | -42% |
| Aerospace & Defense | XAR | -1.3% | -21.5% | -62.3% | -68% |
| Biotech | XBI | -4.4% | -17.8% | -30.5% | -12% |
| Homebuilder | XHB | -5.9% | -21.5% | -36.5% | -25% |
| Retail | XRT | -6% | -19.4% | -39.4% | -30% |
VIMAB vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | -4.3% | -22.9% | -35.3% | -12% |
| Natural Gas | UNG | 6.1% | -4.6% | -26.9% | -17% |
| Gold | GLD | -3.7% | -13.2% | -64.3% | -58% |
| Silver | SLV | -4.4% | -21.4% | -61% | -37% |
| Copper | CPER | -2.5% | -19% | -60.8% | -30% |
VIMAB vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | -1.6% | -15.5% | -40.3% | -17% |
| iShares High Yield Corp. Bond | HYG | -2.2% | -16% | -42.6% | -29% |